Loading...
Docoh

Bill & Melinda Gates Foundation

Filed: 15 Nov 21, 4:08pm

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number:3235-0006
Expires:Oct 31, 2018
Estimated average burden
hours per response:23.8

COLUMN 1COLUMN 2COLUMN 3COLUMN 4COLUMN 5COLUMN 6COLUMN 7COLUMN 8
VALUESHRS ORSH/PUT/INVESTMENTOTHERVOTING AUTHORITY
NAME OF ISSUERTITLE OF CLASSCUSIP(x$1000)PRN AMTPRNCALLDISCRETIONMANAGERSOLESHAREDNONE
AMYRIS INCCOM NEW03236M2004,800292,398SH SOLE 292,39800
ATRECA INCCL A COM04965G10912,0001,396,644SH SOLE 1,396,64400
BIONTECH SESPONSORED ADS09075V102233,0001,038,674SH SOLE 1,038,67400
BUTTERFLY NETWORK INCCL A COM12415510215,0001,011,003SH SOLE 1,011,00300
CUREVAC N VCOMN2451R105230,0003,134,780SH SOLE 3,134,78000
IMMUNCORE HLDGS PLCADS45258D10523,000576,923SH SOLE 576,92300
VIR BIOTECHNOLOGY INCCOM92764N102131,0002,777,777SH SOLE 2,777,77700
ZYMERGEN INCCOM98985X1002,00059,970SH SOLE 59,97000